83249-04-1Relevant articles and documents
ANALGESIC COMPOUNDS
-
Paragraph 0291, (2018/12/13)
Disclosed herein are compounds of Formulae (la), (lb), (Ic), (Id), (le), (If), (Ig), (Ih), (Ik), (Im), (In), (Io), (Ip), (Iq), (Ir), (Is) and (It), methods of synthesizing compounds of Formulae (la), (lb), (Ic), (Id), (le), (If), (Ig), (Ih), (Ik), (Im), (In), (Io), (Ip), (Iq), (Ir), (Is) and (It), and methods of using compounds of Formulae (la), (lb), (Ic), (Id), (le), (If), (Ig), (Ih), (Ik), (Im), (In), (Io), (Ip), (Iq), (Ir), (Is) and (It) as an analgesic.
COMPOUNDS
-
, (2016/02/12)
The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example Alzheimer's disease.
Formation and reactions of bicyclo[1.1.1]pentyl-1 cations
Wiberg, Kenneth B.,McMurdie, Neil
, p. 11990 - 11998 (2007/10/03)
The ionization of 1-bicyclo[1.1.1]pentyl halides was shown to initially form the 1,3-bridged bicyclo[1.1.1]pentyl-l cation. It appears to be a transition state that leads to the bicyclo[1.1.0]butyl-1-carbinyl cation which can be trapped with azide ion and